Valproic acid Completed Phase 4 Trials for Bipolar Disorder (BD) / Mania Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00254488Treatment of Bipolar Mania in Older Adults
NCT00181727Study of Depakote ER for the Treatment of Mania in Children Ages 6-12 With Bipolar Disorder
NCT00397020Naturalistic Study, Comparison of Divalproex Extended Release (ER) and Quetiapine for Adults With Acute Mania or Mixed Episodes
NCT00226343Depakote-ER for Depressive and Bipolar Depression
NCT00048802Treatment and Outcome of Early Onset Bipolar Disorder
NCT00094549Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I Disorder
NCT00177567Treatment of Geriatric Bipolar Mood Disorders: A Pilot Study
NCT00199966Safety And Efficacy Study Of Depakote ER To Treat Pediatric Bipolar Disorder
NCT00261443A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania
NCT00264173VALID : VAlproate Versus LIthium in Bipolar Disorders
NCT00431522Valproic Acid Sodium Salt in Bipolar Disorder
NCT00477373Gulf Evaluation of VAlproate (Depakine Chrono) in maNia Study
NCT00484471ABLE: Abilify in Bipolar Disorder for Long-term Effectiveness
NCT00545675Abilify in Bipolar Disorder for 24 Weeks Treatment Effectiveness
NCT00545142Abilify in Bipolar Disorder for 6 Weeks Treatment Effectiveness
NCT02870283Cost- Effectiveness and Quality of Life Assessment in Mood Disorder